top of page

Imaging and Tumour Metabolism

Using imaging to improve brain tumour surgery

Work in the Price laboratory, along with collaborators, is looking to optimise identification of normal brain physiology, optimise identification of site of recurrence and target treatment e.g. radiotherapy to high risk areas.

Using imaging to characterise brain tumours for precision therapy

Work in the Brindle group is using deuterium weighted and hyperpolarized carbon-based imaging, and mass spectrometry imaging to identify and characterise phenotypic heterogeneity and identify drug:tumour metabolic phenotype pairings.


bottom of page